FDA Announces Meetings of Clinical Hold Oversight Committee for Review of Investigational Biological Product Trials

Summary

The FDA is hosting a series of meetings to review clinical hold orders on investigational biological product trials, allowing companies to submit confidential review requests for trials placed on hold in the past year.